Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular and endosomal lipid bilayer membranes are fundamental structural components that define the boundaries of the cell and its internal compartments. Composed primarily of phospholipids, cholesterol, and proteins, these membranes serve as selective barriers that regulate the transport of ions and molecules while providing a platform for critical signaling pathways (Source: NIH, Molecular Biology of the Cell). In pharmacology, these membranes are targeted by various anti-infective agents that exploit differences in lipid composition between host and pathogen, such as the presence of ergosterol in fungi or specific lipopolysaccharides in bacteria (Source: StatPearls). Furthermore, the endosomal membrane is a significant hurdle and target for the delivery of nucleic acid therapeutics, where successful 'endosomal escape' is required for efficacy (Source: Nature Reviews Drug Discovery). Dysregulation of membrane dynamics is associated with numerous pathologies, including viral infections, where viruses hijack membrane fusion machinery, and neurodegenerative diseases characterized by impaired endosomal trafficking (Source: PubMed). Consequently, therapeutic strategies often focus on either disrupting these membranes in pathogens or modulating their permeability and fusion properties for drug delivery purposes. The physical state of the membrane, including its fluidity and charge, significantly influences the binding and insertion of membrane-active peptides and small molecules. Targeting these structures requires high precision to avoid off-target effects on host cell membranes, which can lead to significant toxicity.
Pore formation, membrane depolarization, surfactant-like disruption of lipid integrity, modulation of membrane fluidity, and induction of endosomal escape via membrane destabilization or fusion.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular and endosomal lipid bilayer membranes.